When your skin is red, itchy, and irritated, it could be a rash or it might be hives. We spoke with experts to learn how to ...

Urticaria highlights from AAD 2025 include late-breaking results from a phase 1b/2a study of the anti-c-Kit antibody placulumab, and positive results from the phase 3 studies of remibrutinib.

Chronic spontaneous urticaria is an idiopathic syndrome defined by recurring itch, hives, or angioedema (or a combination of these symptoms) for more than 6 weeks. Remibrutinib, an oral ...

Adults with chronic spontaneous urticaria experienced greater mortality, probably due to increased risks for comorbidities, ...

CSU is also known as chronic hives. While many people experience hives at some point in life, CSU is characterized by recurring swollen, itchy blotches that can persist for longer than six weeks.

Novartis is just months away from filing for approval of oral BTK inhibitor remibrutinib as a treatment for chronic spontaneous urticaria – also known as chronic hives – after reporting long ...

The following is a summary of “Patient and physician perspectives on disease burden in chronic spontaneous urticaria,” ...